Re-sensitising XDR biofilms using a combination of bacteriophage cocktails and colistin: a natural approach
Re-sensitising XDR biofilms using a combination of bacteriophage cocktails and colistin: a natural approach
复制标题
DOI:
10.1101/2022.02.04.479063
复制
发表时间:
2022-02
期刊:
影响因子:
--
通讯作者:
N. D. Devanga Ragupathi;D. M. Muthuirulandi Sethuvel;M. Gopikrishnan;D. Murugan;R. Juliet;M. Majhi;Malathi Murugesan;G. C;Leshan Wannigama;P. Monk;E. Karunakaran;B. Veeraraghavan
中科院分区:
文献类型:
--
作者:
N. D. Devanga Ragupathi;D. M. Muthuirulandi Sethuvel;M. Gopikrishnan;D. Murugan;R. Juliet;M. Majhi;Malathi Murugesan;G. C;Leshan Wannigama;P. Monk;E. Karunakaran;B. Veeraraghavan
Persistent antibiotic use results in the rise of antimicrobial resistance with limited or no choice for multidrug resistant (MDR) and extensively drug resistant (XDR) bacteria. This necessitates a need for alternative therapy to effectively combat clinical pathogens that are resistant to last resort antibiotics. The study investigates hospital sewage as a potential source of bacteriophages to control MDR/XDR bacterial pathogens. 81 samples were screened for phages against selected clinical pathogens. 10 phages were isolated against A. baumannii, 5 phages against K. pneumoniae and 16 phages obtained against P. aeruginosa. The novel phages were observed to be strain-specific with a complete growth inhibition of up to 6 hrs. Phage plus colistin combinations further reduced the MBEC of colistin up to 16 folds. Notably, cocktail of phages exhibited supreme efficacy with complete killing at 0.5-1 µg/ml colistin concentrations. Thus, phages specific to clinical strains has a higher edge in treating nosocomial pathogens with their proven anti-biofilm efficacy. In addition, analysis of phage genomes revealed close phylogenetic relations with phages reported from Europe, China and other neighbouring countries. This study serves as a reference and can be extended to other antibiotics and phage types to assess optimum synergistic combinations to combat various drug resistant pathogens in the ongoing AMR crisis.